Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Project title: NHS National Framework for Denosumab Injection commencing 1st January 2026
Offer reference number: CM/TNS/25/5725
Period of framework: 1 January 2026 to 31 December 2026 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.
CM/TNS/25/5725/01 - Regional award for Denosumab Injection:
NOFE: (North of England) 01/01/2026 to 31/12/2026 (12 months)
SOFE: (South of England) 01/01/2026 to 31/12/2026 (12 months)
MAE: (Midlands and East) 01/01/2026 to 31/12/2026 (12 months)
LNW: (London) 01/01/2026 to 31/12/2026 (12 months)
CM/TNS/25/5725/02 - National award for Denosumab Injection:
7NAT (National) 01/01/2026 to 31/12/2026 (12 months)
Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
NOTE: Please see Attached Contract Copy document for the list of Unsuccessful Suppliers.
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| Accord-UK Ltd | 00079585 | £37,694,000 | 1 lot CM/TNS/25/5725/01 - Regional award for Denosumab Injection | - |
| Amgen Ltd | 02354269 | £15,059,000 | 1 lot CM/TNS/25/5725/02 - National award for Denosumab Injection | - |
| Biosimilar Collaborations Ireland Limited | Procurement ID: PQQC-5869-LMVX | £37,694,000 | 1 lot CM/TNS/25/5725/01 - Regional award for Denosumab Injection | - |
| Celltrion Healthcare United Kingdom Limited | 11685363 | £37,694,000 | 1 lot CM/TNS/25/5725/01 - Regional award for Denosumab Injection | - |
| Fresenius Kabi Limited | 02182135 | £15,059,000 | 1 lot CM/TNS/25/5725/02 - National award for Denosumab Injection | - |
| Gedeon Richter UK Ltd | 04325685 | £37,694,000 | 1 lot CM/TNS/25/5725/01 - Regional award for Denosumab Injection | - |
| Teva UK Limited | 00302461 | £37,694,000 | 1 lot CM/TNS/25/5725/01 - Regional award for Denosumab Injection | - |
| Zentiva Pharma UK Ltd | 02158996 | £37,694,000 | 1 lot CM/TNS/25/5725/01 - Regional award for Denosumab Injection | - |
This procurement was divided into 2 lots, each awarded separately. 15 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 1 CM/TNS/25/5725/01 - Regional award for Denosumab Injection Jan 2026 – Dec 2026 | £36,000,000 £37,694,000 initial term | 13 | Biosimilar Collaborations Ireland Limited | active |
| Lot 2 CM/TNS/25/5725/02 - National award for Denosumab Injection Jan 2026 – Dec 2026 | £21,000,000 £15,059,000 initial term | 2 | active |
Notices published under the Procurement Act 2023 name every bidder, including unsuccessful ones.
| Bidder | Bid on | Outcome |
|---|---|---|
| ACCORD-UK LTD | Lot 1 | Wonlot 1 |
| AMGEN LIMITED | Lots 2, 1 | Wonlot 2 |
| Biosimilar Collaborations Ireland Limited | Lot 1 | Wonlot 1 |
| CELLTRION HEALTHCARE UNITED KINGDOM LIMITED | Lot 1 | Wonlot 1 |
| FRESENIUS KABI LIMITED | Lots 2, 1 | Wonlot 2 |
| GEDEON RICHTER (UK) LIMITED | Lot 1 | Wonlot 1 |
| TEVA UK LIMITED | Lot 1 | Wonlot 1 |
| ZENTIVA PHARMA UK LIMITED | Lot 1 | Wonlot 1 |
| DR REDDY'S LABORATORIES (UK) LIMITED | Lot 1 | Unsuccessful |
| SAMSUNG BIOEPIS UK LIMITED | Lot 1 | Unsuccessful |
| SANDOZ LIMITED | Lot 1 | Unsuccessful |
| THERAMEX HQ UK LIMITED | Lot 1 | Unsuccessful |
| THORNTON & ROSS LIMITED | Lot 1 | Unsuccessful |
Weightings from the notice, applied to every lot.
Government spending data: These suppliers have received £161,876,150 in 3,582 payments (over £25k) from Department of Health and Social Care, NHS Supply Chain (DHSC-funded), Guy's and St Thomas' NHS FT, NHS England, University Hospitals Bristol and Weston NHS FT and 11 more public bodies (2010-04-28 to 2026-03-31).